MPN Voice

Dr. J.J. Kiladjian at ASH 2017, Ropeginterferon Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients

Dr. J.J. Kiladjian at ASH 2017, Ropeginterferon Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients

Two Year Results from the First Prospective Randomized Controlled Trial -

pvreporter.com/dr-jean-jacq...

Hope you find the interview informative.

Best,

David Wallace - PV Reporter

2 Replies
oldestnewest

It does seem that interferon is becoming the stronger option.

Thanks

Reply

It would be my first choice, but all patients are different. This option should be discussed with your hematologist to weigh the pros and cons.

1 like
Reply